PRRT2 and Hyperglycemia: The general PKC inhibitor staurosporine and the classical PKC inhibitor Go6976 reduce hyperglycemia-associated endothelial monolayer permeability suggesting that hyperglycemia-induced PKC signaling promotes endothelial permeability [257, 258].